University of California San Francisco
After a seven-year hiatus, UCSF’s Block Party welcomed more than 1,500 UCSF faculty, staff and learners. Booths representing many of UCSF’s programs and offices lined the plaza, along with live music, a chalk drawing contest, and competitive games of cornhole and Jenga.
Suneil Koliwad weighs in on the state of insulin production after California Governor Gavin Newsom vetoed a law that would cap the price for consumers at $35 a month. California will focus instead on producing its own insulin for $30 per vial.
Charles “Chuck” Feeney, one of UCSF’s greatest supporters and friends and the man Forbes magazine named America’s most generous philanthropist, passed away on October 9, 2023, at the age of 92.
UCSF's HS PROGRESS study aims to understand and treat Hidradenitis Suppurativa, an often debilitating condition disproportionately affecting women and people of color.
UCSF transplant surgeon Sandy Feng, MD, PhD, has been elected to the National Academy of Medicine, one of the most prestigious organizations in health and medicine.
Katina Bitsicas, UCSF’s newest Artist in Residence, is embarking on an immersive project aimed at creating “a visual representation of the destruction that’s happening in our bodies and ecosystems” connected to the common herbicide glyphosate.
Diana Greene Foster, leader of a groundbreaking study on what happens to women who are denied abortions, has been named a 2023 MacArthur Fellow, one of the most coveted honors in academia, science and the arts.
Angela Woon, an IT Communications Analyst at UCSF, avid runner, and writer, shares her story and experience with Retinitis Pigmentosa (RP), a condition that will eventually cause her sight to fully deteriorate.
Patients of acute kidney injury might not need as much dialysis as patients with end-stage kidney disease, and might benefit more from weaning off dialysis to avoid risk for heart disease, infection, organ damage and death.
With fentanyl overdose deaths at an all-time high, a successful UCSF-funded pilot project to distribute fentanyl test strips is being expanded by California Gov. Gavin Newsome as part of his plan to address the crisis.
A small device placed behind the ear targets the nervous system to help reduce pain and provide relief for kids with irritable bowel syndrome (IBS).
FDA approves palovarotene (Sohonos) for rare FOP, reducing HO by 54%. Significant step in improving lives of affected patients.
Zuranolone (Zurzuvae), the first pill for patients suffering from postpartum depression, is expected to be available by the end of 2023. Though it may relieve depressive symptoms, it has some drawbacks such as sedation and dangers in breastfeeding.
Camp Winning Hands is a free summer camp for kids and teens with limb differences, where campers enjoy all types of activities that are modified for their unique conditions.
UCSF students and postdocs join advocates from around the country for the 2023 Rally for Medical Research to call on our nation’s policymakers to make funding for NIH a national priority and raise awareness about the importance of continued investment in medical research.
Vizient Inc. has named UCSF Health as a Top Performer for its high-quality patient care in the 2023 Bernard A. Birnbaum, MD, Quality Leadership Ranking.
Laura Persson, PhD, wins the 2023 Postdoc Slam with her talk titled “The Wormnado: What a tiny worm can teach us about collective behavior.”
Convergent evolutionary mechanisms shared by COVID-19 variants allow them to overcome both adaptive and innate immune system barriers.
UCSF has been given the green light on a new research and academic building at Parnassus Heights, creating a vital collaborative space to drive innovations in scientific research and education.
UCSF Health achieves 150 robotic focal HIFU procedures for prostate cancer, pioneering precision therapy with minimal side effects, prioritizing quality of life preservation.
Recommendations are in place for the updated COVID-19 vaccine from Pfizer-BioNTech and Moderna.
Discoveries result from a mix of smarts, creativity, grit, collaboration, serendipity and time. But when scientists must constantly apply for funding, that last factor can be hard to come by. The Arc
A clinical trial showed that MDMA, the so-called psychedelic drug also known as "ecstasy" or "molly," can be a powerful new tool in treating people with moderate-to-severe PTSD.
Using both cannabis and tobacco increases depression and anxiety risk, highlighting the need for integrated support, says UC San Francisco study.